Pathogenesis, Treatment Advances, and Renal Outcomes in Childhood-Onset Lupus Nephritis
Author:
Open Access
- 18 February 2026
- journal article
- review article
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 65 (7) , 975-987
Abstract
Systemic lupus erythematosus is defined as an autoimmune and inflammatory disease that is distinguished by the involvement of diversified multisystem and a persistent course with unpredictable flares. Immune complex-mediated glomerulonephritis is the main presentation of renal involvement and is commonly regarded as lupus nephritis (LN). Although the long-term renal prognosis has been considerably improved, a significant morbidity and mortality is still experienced by children and adolescents with LN. Furthermore, present literature is insufficient with regard to data related to pediatrics, resulting in clinicians to depend entirely on therapeutic approaches employed for adults. Treatment protocols have been produced by various international groups that recommend an intense duration of immunosuppression to stop the process of acute renal inflammation, with subsequent maintenance therapy and close monitoring for disease improvement and rapid assessment of disease flares. Prevalence of renal remission is suboptimal indicating only 40% to 60% of patients attaining complete remission. The rate of chronic kidney disease (CKD) stage V has been observed to be at least 15% and the presence of LN has an association with high mortality rates. In ascertained renal failure, renal transplantation is implied to be the most favorable modality of renal replacement therapy in this specific patient group. This review aims to describe childhood-onset LN and provide an overview on the pathogenesis, therapeutic approaches, emerging therapies and present renal outcomes for this disease with the objective of recognizing the key features that might aid in reducing the risk of long-term CKD.Keywords
This publication has 116 references indexed in Scilit:
- Epidemiology of Childhood‐Onset Systemic Lupus Erythematosus: A Population‐Based StudyArthritis Care & Research, 2022
- Pain, Fatigue, and Psychological Impact on Health‐Related Quality of Life in Childhood‐Onset LupusArthritis Care & Research, 2015
- Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US medicaid beneficiary populationArthritis & Rheumatism, 2012
- American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritisArthritis Care & Research, 2012
- Disease activity, severity, and damage in the UK juvenile‐onset systemic lupus erythematosus cohortArthritis & Rheumatism, 2012
- Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosusArthritis Care & Research, 2011
- B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patientsArthritis & Rheumatism, 2009
- Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: Data from a single US institutionArthritis & Rheumatism, 2009
- Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohortArthritis Care & Research, 2009
- Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamideArthritis & Rheumatism, 2002